Microfluidic Chip Simulating Blood Flow Shear Stress for Endothelial Glycocalyx Research
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro cell culture methods for studying endothelial glycocalyx do not accurately mimic dynamic flow conditions, leading to differences between in vitro and in vivo endothelial glycocalyx and hindering research and development of cardiovascular disease therapies.
Innovation Solution
A microfluidic chip with a multichamber flow assembly and a porous biocompatible membrane is used to culture endothelial cells, allowing for the simulation of blood flow shear stress and measurement of endothelial glycocalyx thickness and integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional in vitro cell culture methods are used to study endothelial glycocalyx, then the experimental setup is simple and easy to maintain, but the results do not accurately reflect in vivo physiological conditions
Solution Approach 1:
The patent creates a simplified copy of the in vivo blood vessel environment by fabricating a microchannel with endothelial cells and glycocalyx that replicates key physiological features (flow conditions, shear stress, glycocalyx formation) without requiring complex in vivo systems. This allows accurate modeling of endothelial glycocalyx pathogenesis while maintaining experimental simplicity.
2Reliability
If static cell culture conditions are used, then the culture system is easy to operate, but the endothelial glycocalyx structure and function differ from in vivo conditions
Solution Approach 1:
The patent transforms the static cell culture system into a dynamic one by implementing a microfluidic flow system that continuously perfuses culture medium through the microchannel at controlled flow rates. This dynamic flow condition reproduces in vivo blood flow shear stress, enabling formation and maintenance of physiologically relevant endothelial glycocalyx while remaining operationally simple through automated pumping.
3Reliability
If in vivo models are used to study endothelial glycocalyx, then physiological accuracy is high, but the system is complex and difficult to control
Solution Approach 1:
The patent extracts the essential functional components of the in vivo blood vessel system (endothelial cells, glycocalyx, flow conditions) and isolates them in a simplified microchannel environment. This extraction allows study of endothelial glycocalyx pathogenesis with high physiological accuracy while eliminating the complexity of whole-organism systems.
4Reliability
If high flow rates are applied to mimic blood flow, then glycocalyx formation is improved, but cell culture conditions become more difficult to control
Solution Approach 1:
The patent systematically optimizes flow rate parameters to achieve the optimal balance between glycocalyx formation and culture control. By adjusting flow rate, viscosity, and pressure parameters within specific ranges, the system achieves physiologically relevant glycocalyx integrity while maintaining stable and controllable cell culture conditions through precise parameter management.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic chip effectively mimics physiological conditions, enabling the study of endothelial glycocalyx-mediated pathogenesis and the screening of compounds that protect and regenerate the endothelial glycocalyx, thus facilitating the development of therapeutic interventions for cardiovascular diseases.
Implementation Method 1
a porous biocompatible membrane oriented along a longitudinal interface between the first microchannel and the second microchannel, wherein the porous biocompatible membrane is permeable for movement of biomolecules from the first chamber to the second chamber through the porous biocompatible membrane
Implementation Method 2
increasing the flow rate of cell culture medium to a high flow rate to mimic blood flow shear stress in vivo to increase growth of an endothelial glycocalyx on the endothelial cells
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The microfluidic chip can comprise at least one multichamber flow assembly (500) that can comprise a plurality of microchannels. The plurality of microchannels can comprise a first microchannel (512) that includes: a first inlet; a first outlet; and a first chamber fluidly connected to the first inlet and the first outlet. The plurality of microchannels can comprise a second microchannel (514) that includes: a second inlet; a second outlet; and a second chamber fluidly connected to the second inlet and the second outlet. The multichamber flow assembly (500) can comprise a porous biocompatible membrane (513) oriented along a longitudinal interface between the first microchannel (512) and the second microchannel (514), wherein the porous biocompatible membrane (513) is permeable for movement of biomolecules from the first chamber (512) to the second chamber (514) through the porous biocompatible membrane (513).